Lettre ouverte de Médecins Sans Frontières au Fonds mondial de lutte contre le sida, la tuberculose et le paludisme

MSF exprime ses préoccupations au sujet des politiques du Fonds mondial sur l’allocation, le cofinancement et la transition pour les prochaines phases de financement. Pour en savoir plus, en anglais, veuillez lire les informations ci-dessous.

Abonnez-vous à l'Alerte mensuelle de l'IDPC pour recevoir des informations relatives à la politique des drogues.

By Médecins Sans Frontières

Dear Secretariat and Board of the Global Fund,

We are writing to you on behalf of Médecins Sans Frontières (MSF) to convey our concerns about the Global Fund’s policies on allocation, co-financing, and transition, as the Board and Secretariat prepare to roll out its next funding allocations to countries.

New diagnostics and treatments have substantially improved outcomes among people with HIV, hepatitis C virus (HCV) and drug-resistant tuberculosis (DR-TB). But we fear that shifts in Global Fund policies will hinder countries from providing these innovations to patients, and limit their ability to procure - and use - quality and affordable drugs and diagnostics.

MSF urges the Global Fund to freeze implementation of transition plans until a risk assessment of its new allocation policies, strategies for procurement and transition plans has been conducted, and until a roadmap for scaling up access to optimal new diagnostics and treatments has been created.

Click here to read the full letter

Keep up-to-date with drug policy developments by subscribing to the IDPC Monthly Alert.